Morgan Stanley reaffirmed their overweight rating on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) in a report ...

In a report released today, Michael Sanderson from Barclays maintained a Sell rating on abrdn (ABDN – Research Report), with a price target of ...

Morgan Stanley reaffirmed their overweight rating on shares of Centessa Pharmaceuticals (NASDAQ:CNTA – Free Report) in a research report report published on Friday,Benzinga reports. The firm currently ...

Barclays analyst Mathieu Robilliard maintained a Buy rating on Iridium Communications (IRDM – Research Report) today and set a price target of ...

Lloyds share price continued its strong surge this year as European bank stocks soared and after publishing strong financial ...

Morgan Stanley analyst Megan Alexander maintained an Equal-Weight rating with a price target of $197 on Dec. 23, 2024. This ...

As earnings season begins, filings to the SEC point to uncertainty from the current administration as potential trouble for ...

US stocks are at risk of slumping another 5% on worries about the hit to corporate earnings from tariffs as well as lower ...

A Morgan Stanley analyst identifies the point where investors might find an attractive entry point to get back in the market.

Barclays PLC has repurchased 2,008,000 of its ordinary shares from J.P. Morgan Securities plc as part of its ongoing share buy-back program announced in February 2025. The repurchased shares will be ...